Market Place
Sourcing Support
Taiho Oncology to Present Data at 66th ASH 2024
05 Nov 2024 //
PR NEWSWIRE
Taiho Announces Publication of Final Results of Phase 3 of Decitabine and Cedazuridine
23 Jan 2024 //
PR NEWSWIRE
Taiho Announces Presentation of Data of Oral Decitabine and Cedazuridine
10 Dec 2023 //
PR NEWSWIRE
Taiho and Astex Announce Data Presentations at the 65th ASH Annual Meeting
17 Nov 2023 //
PR NEWSWIRE
Boundless Bio Announces Agreement with Taiho Oncology to Evaluate LYTGOBI
18 Sep 2023 //
BUSINESSWIRE
Federal court judge rules in favor of Otsuka`s Taiho in Lonsurf patent suit
17 Aug 2023 //
ENDPTS
REZILIENT3 Global First-Line Trial of Zipalertinib Launched for NSCLC
03 Aug 2023 //
PR NEWSWIRE
FDA approves Taiho`s Lonsurf with bevacizumab for metastatic colorectal cancer
03 Aug 2023 //
ENDPTS
FDA Approves LONSURF in Combination With Bevacizumab for mCRC
02 Aug 2023 //
PR NEWSWIRE
EC Grants Conditional Marketing Authorization for Taiho`s Lytgobi Tablets
05 Jul 2023 //
PR NEWSWIRE
Taiho Oncology & Servier Announce in New Engl& Journal pH 3 Data for (LONSURF®)
03 May 2023 //
BUSINESSWIRE
U.S. FDA Accepts for Priority Review Taiho Onc`s sNDA for Trifluridine/Tipiracil
18 Apr 2023 //
PR NEWSWIRE
Taiho to Publish in The New England Journal of Medicine for Futibatinib
18 Jan 2023 //
PR NEWSWIRE
FDA greenlights Otsuka subsidiary`s bile duct cancer drug
04 Oct 2022 //
ENDPTS
Ascelia Pharma Signs Clinical Collaboration Agreement With Taiho Oncology
21 Sep 2021 //
FIRSTWORDPHARMA
NCCN Projects to Study Oral Decitabine &Cedazuridine in Collab Taiho Oncology
14 Apr 2021 //
PRNEWSWIRE
Taiho Oncology Announces Presentation of Phase 2 Data for Futibatinib (TAS-120)
13 Apr 2021 //
PRNESWIRE
Taiho Oncology To Present Phase 2 Data for Futibatinib (TAS-120)
02 Apr 2021 //
PRNEWSWIRE
National Comprehensive Cancer Network® Provides Updates on Use of LONSURF®
04 Feb 2021 //
PRNNEWSWIRE
Taiho Oncology, Inc. Announces Establishment of European Headquarters
15 Jan 2021 //
PRNEWSWIRE
Taiho Oncology and Servier To Present Data on LONSURF®
12 Jan 2021 //
PRNEWSWIRE
Taiho and Astex To Present Data In Myelodysplastic Syndromes at the 62nd ASH
02 Dec 2020 //
PRNEWSWIRE
Taiho Oncology and Astex Pharmaceuticals To Present Data In Myelodysplastic
02 Dec 2020 //
PRNEWSWIRE
National Comprehensive Cancer Network® Adds INQOVI®
23 Nov 2020 //
BIOSPACE
National Comprehensive Cancer Network® Adds INQOVI®
23 Nov 2020 //
PRNEWSWIRE
Taiho and Lung Enter Into an Exclusive License Agreement in Japan for LTI-01
12 Nov 2020 //
BUSINESSWIRE
Taiho Oncology Launches World of Hope Campaign to Support MDS World
23 Oct 2020 //
PRNEWSWIRE
Taiho Oncology Launches World of Hope Campaign to Support MDS
22 Oct 2020 //
PRNEWSWIRE
Taiho Oncology To Present Futibatinib (TAS-120) Data at ESMO Virtual Congress
15 Sep 2020 //
PRNEWSWIRE
Taiho Oncology To Present Data on Futibatinib (TAS-120) at the AACR
04 Jun 2020 //
PRNEWSWIRE
Taiho Oncology Announces Presentation of Data for Futibatinib at 2020 ASCO
30 May 2020 //
PRNEWSWIRE
